Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Dig Dis Sci. 2016 Apr 28;61(9):2602–2607. doi: 10.1007/s10620-016-4171-9

Table 1.

Patient and surgery characteristics (N=47)

Age, Mean (range) 34.57 years (10–63 years)
Gender, total (%) Male 27 (57.45%)
Female 20 (42.55%)
Disease type, total (%) Crohn’s 35 (74.47%)
UC 12 (25.53%)
Preoperative steroid use, total (%) Yes 15 (31.91%)
No 32 (68.09%)
Time between last dose and surgery, Mean (range) 39.81 days (3 days to > 90 days)
Preoperative status, total (%) Infection 9 (19.15%)
No infection 38 (80.85%)
Surgery site, total (%) Intra-abdominal 35 (74.47%)
Perianal 12 (25.53%)
Surgery type, total (%) Elective 38 (80.85%)
Urgent 9 (19.15%)
Surgeon type, total (%) Colorectal 42 (89.36%)
General 5 (10.64%)
Complications, total (%) Yes 8 (17.02%)
No 39 (82.98%)

Note: All 47 subjects are on Infliximab.